mutLBSgeneDB |
Gene summary for CAMK2D |
Gene summary |
Basic gene Info. | Gene symbol | CAMK2D |
Gene name | calcium/calmodulin-dependent protein kinase II delta | |
Synonyms | CAMKD | |
Cytomap | UCSC genome browser: 4q26 | |
Type of gene | protein-coding | |
RefGenes | NM_001221.3, NM_172114.1,NM_172115.2,NM_172127.2,NM_172128.2, NM_172129.1, | |
Description | CaM kinase II delta subunitCaM-kinase II delta chainCaMK-II delta subunitcaM kinase II subunit deltacaMK-II subunit deltacalcium/calmodulin-dependent protein kinase (CaM kinase) II deltacalcium/calmodulin-dependent protein kinase type II delta chain | |
Modification date | 20141207 | |
dbXrefs | MIM : 607708 | |
HGNC : HGNC | ||
Ensembl : ENSG00000145349 | ||
HPRD : 09653 | ||
Vega : OTTHUMG00000132910 | ||
Protein | UniProt: Q13557 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CAMK2D | |
BioGPS: 817 | ||
Pathway | NCI Pathway Interaction Database: CAMK2D | |
KEGG: CAMK2D | ||
REACTOME: CAMK2D | ||
Pathway Commons: CAMK2D | ||
Context | iHOP: CAMK2D | |
ligand binding site mutation search in PubMed: CAMK2D | ||
UCL Cancer Institute: CAMK2D | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0003254 | regulation of membrane depolarization | 22514276 | GO:0006468 | protein phosphorylation | 17179159 | GO:0018105 | peptidyl-serine phosphorylation | 22514276 | GO:0018107 | peptidyl-threonine phosphorylation | 22514276 | GO:0046777 | protein autophosphorylation | 22514276 | GO:0051259 | protein oligomerization | 20668654 | GO:1901897 | regulation of relaxation of cardiac muscle | 23283722 | GO:1902306 | negative regulation of sodium ion transmembrane transport | 22514276 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity | 22514276 |
Top |
Ligand binding site mutations for CAMK2D |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | K22 | A24T | HNSC | 1 | V28 | V28L | LUAD | 1 | V28 | S26L | LUSC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for CAMK2D |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | K22 | A24T | -0.87960345 | V28 | V28L | -0.37639201 | V28 | S26L | -0.003823637 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for CAMK2D from PDB |
Top |
Differential gene expression and gene-gene network for CAMK2D |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for CAMK2D |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0151744 | Myocardial Ischemia | 1 | Biomarker |
umls:C0032460 | Polycystic Ovary Syndrome | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for CAMK2D |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Experimental | DB07853 | [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE | Small molecule | |
Experimental | DB08039 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of CAMK2D go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | GVD | [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE | 2vn9 | A | K22 V28 | GVD | [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE | 2vn9 | B | K22 V28 | K88 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | 2wel | A | V28 |
Top |
Conservation information for LBS of CAMK2D |
Multiple alignments for Q13557 in multiple species |
LBS | AA sequence | # species | Species | A156 | AAVKLADFGLA | 7 | Homo sapiens, Drosophila melanogaster, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | A41 | TGQEYAAKIIN | 6 | Homo sapiens, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | A41 | TGFEFAAKIIN | 1 | Drosophila melanogaster | D157 | AVKLADFGLAI | 7 | Homo sapiens, Drosophila melanogaster, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | D91 | HYLVFDLVTGG | 7 | Homo sapiens, Drosophila melanogaster, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | F90 | FHYLVFDLVTG | 5 | Homo sapiens, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | F90 | YHYLVFDLVTG | 1 | Drosophila melanogaster | F90 | VHYLVFDLVTG | 1 | Danio rerio | G21 | LFEELGKGAFS | 5 | Homo sapiens, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | G21 | IKEELGKGAFS | 1 | Drosophila melanogaster | G21 | LYEELGKGAFS | 1 | Danio rerio | K22 | FEELGKGAFSV | 5 | Homo sapiens, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | K22 | KEELGKGAFSI | 1 | Drosophila melanogaster | K22 | YEELGKGAFSV | 1 | Danio rerio | K43 | QEYAAKIINTK | 6 | Homo sapiens, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | K43 | FEFAAKIINTK | 1 | Drosophila melanogaster | L20 | QLFEELGKGAF | 5 | Homo sapiens, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | L20 | DIKEELGKGAF | 1 | Drosophila melanogaster | L20 | QLYEELGKGAF | 1 | Danio rerio | L92 | YLVFDLVTGGE | 7 | Homo sapiens, Drosophila melanogaster, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | V28 | GAFSVVRRCMK | 6 | Homo sapiens, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus | V28 | GAFSIVKRCVQ | 1 | Drosophila melanogaster | V93 | LVFDLVTGGEL | 7 | Homo sapiens, Drosophila melanogaster, Danio rerio, Gallus gallus, Rattus norvegicus, Bos taurus, Mus musculus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |